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Case Report: A Patient with Gait Dysfunction with Acute Inflammatory Demyelinating Polyneuropathy
Masquerading as Diabetic Polyneuropathy
David Parkes, Russell Mordecai
Department of Emergency Medicine Jefferson NJ and Emergency Medicine Residency Rowan University SOM/Jefferson NJ

Abstract:
New onset gait dysfunction often prompts admission to the hospital for
further evaluation. The typical patient is an elderly person who normally is
self-sufficient but had recently experienced a decline in their ability to care
for themselves. Sometimes, however, those who present with gait
dysfunction do not fit the expected demographic. These individuals raise
concern for less common “zebra” presentations of neurological
dysfunction. We describe one such rare case of a 39-year-old female with a
new onset of type 2 diabetes mellitus and recent COVID-19 infection that
presented to the emergency department with a sensation of bilateral lower
extremity burning with sensorineural changes, weakness, and an inability
to ambulate. Emergency department labs and preliminary imaging were
grossly unremarkable. Treatment as an inpatient with IVIG led to significant
improvement in symptoms. Gait dysfunction is a common presentation in
the ED. Recognizing abnormalities to the typical demographic and
presentation are important in proper disease workup and remaining
vigilant in the face of atypical diagnoses.

Introduction:
Acute inflammatory demyelinating polyneuropathy, also known as GuillainBarre (GBS) syndrome is an acute polyneuropathy caused by immunemediated peripheral nerve sheath destruction. Acquired polyneuropathies
are known to be associated with vaccinations, autoimmune disorders,
Lupus, IBD, DM, acquired immunodeficiencies, neoplastic processes, toxins,
recent surgery, and the postpartum state. The typical patient presents with
ascending, clinically significant symmetric weakness or even paralysis.
These patients also often present with a loss of deep tendon reflexes
(DTRs). The largest concern from an emergency standpoint is when this
ascending weakness/paralysis reaches the diaphragm necessitating acute
and critical interventions. The clinical term of the diagnosis widely varies
from days to weeks with recovery extending up to and sometimes beyond
6 weeks. GBS is more accurately classified as a spectrum of disease states
that include AIDP, acute motor-sensory axonal neuropathy, acute motor
axonal neuropathy, and Miller-Fisher syndrome.
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Case:
A 39-year-old female with a history of T2DM with diabetic neuropathy
diagnosed 2 weeks prior presents to the ED with a chief complaint of
bilateral lower extremity pain described as a “burning” sensation for the
past 2-3 days. The patient had been following with endocrine since her
diabetic diagnosis and was taking Metformin, Glipizide, and Neurontin for
neuropathic pain. She claimed that she was previously a healthy person
with no significant medical problems until she contracted COVID-19 two
months prior to her visit (1/18/22).6 days after the patient’s COVID-19
diagnosis (1/24/22) she presented to the emergency department
complaining of fatigue, headache, cough, body aches, and
nausea/vomiting. At the time she had already received the Johnson &
Johnson vaccine. She was discharged with supportive medications after an
unremarkable X-ray. She was reportedly ambulatory during her stay.
The patient returned to the ED 3 weeks later for evaluation of worsening
bilateral circumferential lower extremity pain and weakness from the knee
down for the past 10 days. She claimed that her symptoms were
noticeable after she had fallen down steps 1 week prior. She described
pain, intermittent numbness, weakness, and decreased sensation in both
lower extremities. She claimed that she had been forced to resort to using
a walker to get around due to the severity of the symptoms. Of note,
during the encounter the patient did admit to heavily drinking for
approximately 4 days per week. Labs were significant for anemia to 6.7,
leukocytosis to 14.5, transaminitis (Alk phos 171, AST 143, and ALT 44),
glucose 656, potassium 3.2, and sodium 127 (corrected to 136). She was
given 1 unit PRBC and was admitted to the hospital for new onset DM,
symptomatic anemia, transaminitis, and hypokalemia.While inpatient she
was started on a diabetic regimen. She continued to complain of bilateral
lower extremity weakness, which was attributed to her anemia/diabetes.
Physical therapy felt that the patient was unable to stand or walk
independently and she had little to no muscle activity/effort. She was
diagnosed with functional limitation and was discharged home on
Neurontin with plans for continued outpatient therapy. Due to her
persisting lower extremity weakness and now pain she returned to the
emergency department. She was re-admitted and evaluated by neurology
who believed that her presentation was sensorimotor distal symmetrical
polyneuropathy concerning for AIDP/CIDP vs. infectious
neoplastic/Paraneoplastic vs. unspecified autoimmune etiology. A
polyneuropathy workup including EMG/NC, MRI C/T/L spine, INR LP with
cell count, and IgA levels was ordered. Her EMG/NCS demonstrated
electrodiagnostic evidence of a moderately involved acute sensorimotor
peripheral neuropathy with evidence of axonal loss and demyelination with
diffuse denervation in the RLE. Eventually, she was diagnosed with AIDP,
which was thought to be secondary to her COVID-19 diagnosis. The patient
was started on a 5-day course of IVIG with improvement of symptoms. A
diagnosis of POEMS was ultimately considered and the patient was
discharged to SAR with plans for a full outpatient rheumatology workup for
further autoimmune disease.

Discussion:
Reasons for gait dysfunction in the emergency department patient can vary
widely. Most reassuring are those that have a clear correlation between labs
and/or imaging and their presentation. More concerning are patients with
an unusual demographic for gait abnormality, acute onset, red flags on
physical exam, and a generally otherwise unremarkable workup. In the
hectic emergency department environment it is extremely easy to accept
bias from the pre-existing conditions that a patient may present with. For
example, little concern for “how did this happen” occurs when a patient with
known hypertension presents with high blood pressures.
Red herring patient presentations are arguably some of the most difficult
diagnoses to make. Overlapping symptoms between possible offending
causes can make the diagnosis that much more difficult. In the diagnosis of
Guillain-Barre/AIDP only two criteria are “required” to raise suspicion [2]
Progressive weakness of more than one limb
Areflexia
Criteria that are more “suggestive” include
Progression over days to weeks
Relative symmetry of symptoms
Recovery 2-4 weeks after progression stops
Autonomic dysfunction
CN involvement
Absence of fever
In the case of gait abnormalities in the emergency department it is first
important to determine if the complaint is sensory, motor, or sensorimotor
[1]. Gait abnormalities as a cause of nervous system dysfunction must be
split into either central or peripheral [1]. Lastly, the timing of the illness must
be considered. Acute onset over days to hours is typically more indicative of
processes that require more immediate intervention (stroke, cauda equina
syndrome, MS exacerbation, etc.). Symptoms over weeks to months suggest
chronicity that is more compatible with outpatient referral.

Conclusion:
We describe the case of AIDP masquerading as diabetic polyneuropathy in the
setting of symptomatic anemia and chronic alcohol abuse in a new diabetic 39year-old female presenting to the emergency department. The patient was
reportedly healthy prior to her diagnosis of COVID-19 one month prior to her
initial emergency department encounter and two months prior to her final
diagnosis encounter. The patient had significant improvement of her symptoms
after EMG/NC studies demonstrated AIDP and she was started on IVIG therapy.
The patient was eventually discharged to SAR for further therapy as an
outpatient. Gait dysfunction is an extremely common emergency department
presentation. Clinical gestalt and required criteria in the face of mimicking
conditions can help distinguish subtle differences. Early neurology consultation
can help further improve patient diagnostics, especially in the acute onset of gait
dysfunction in the abnormal patient demographic. In the unprecedented times
of COVID-19, long term effects of the disease and its outreach have yet to be
fully studied.

